Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood 2017-05, Vol.129 (20), p.2808-2810
Hauptverfasser:	Walter, Harriet S., Jayne, Sandrine, Rule, Simon A., Cartron, Guillaume, Morschhauser, Franck, Macip, Salvador, Karlin, Lionel, Jones, Ceri, Herbaux, Charles, Quittet, Philippe, Shah, Nimish, Hutchinson, Claire V., Fegan, Christopher, Yang, Yingsi, Mitra, Siddhartha, Salles, Gilles, Dyer, Martin J.S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Agammaglobulinaemia Tyrosine Kinase Disease-Free Survival Female Follow-Up Studies Humans Imidazoles - administration & dosage Imidazoles - adverse effects Letter to Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Leukemia, Lymphocytic, Chronic, B-Cell - epidemiology Leukemia, Lymphocytic, Chronic, B-Cell - mortality Life Sciences Male Protein-Tyrosine Kinases - antagonists & inhibitors Pyrimidines - administration & dosage Pyrimidines - adverse effects Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!